Immunocore Holdings plc (IMCR)
$36.62-$0.13 (-0.35%) Today
David M. Berman - OfficerDavid M. Berman - OfficerDavid M. Berman - OfficerDavid M. Berman - OfficerDavid M. Berman - OfficerImmunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
No Form 4 activity for IMCR in the last 90 days.
17 Form 4 filings on record, the earliest from May 15, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Peter John Ratcliffe | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
 Kristine Peterson | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
| William Pao | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
| Siddharth Kaul | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
 Roy Steven Herbst | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
 John Irving Bell | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
| Travis Alan Coy - Officer | Grant or award | Restricted Share Units | 33,353 | $0.00 | - | |
| Travis Alan Coy - Officer | Grant or award | Employee Share Option (Right to Buy) | 95,637 | $0.00 | - | |
| Bahija Jallal - Officer | Option exercise | Ordinary Shares | 23,817 | $0.00 | - | |
| Bahija Jallal - Officer | Open-market sale | Ordinary Shares | 11,474 | $32.35 | $371K | |
| Bahija Jallal - Officer | Option exercise | Restricted Share Units | 23,817 | $0.00 | - | |
| Bahija Jallal - Officer | Grant or award | Restricted Share Units | 88,573 | $0.00 | - | |
| Bahija Jallal - Officer | Grant or award | Employee Share Option (Right to Buy) | 395,066 | $0.00 | - | |
| John Goll - Officer | Option exercise | Restricted Share Units | 1,351 | $0.00 | - | |
| John Goll - Officer | Grant or award | Restricted Share Units | 7,411 | $0.00 | - | |
| John Goll - Officer | Option exercise | Ordinary Shares | 1,351 | $0.00 | - | |
| John Goll - Officer | Open-market sale | Ordinary Shares | 698 | $32.35 | $23K | |
| John Goll - Officer | Grant or award | Employee Share Option (Right to Buy) | 21,252 | $0.00 | - | |
| Leger Tina Amber St - Officer | Option exercise | Ordinary Shares | 2,119 | $0.00 | - | |
| Leger Tina Amber St - Officer | Open-market sale | Ordinary Shares | 1,000 | $32.35 | $32K | |
| Leger Tina Amber St - Officer | Option exercise | Restricted Share Units | 2,119 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 11,824 | $0.00 | - | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 5,965 | $32.35 | $193K | |
| David M. Berman - Officer | Option exercise | Restricted Share Units | 11,824 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 69,404 | $17.46 | $1.21M | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 69,404 | $40.12 | $2.78M | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 5,521 | $17.46 | $96K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 5,521 | $40.09 | $221K | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 69,404 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 5,521 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 100 | $17.46 | $2K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 100 | $40.00 | $4K | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 18,020 | $17.46 | $315K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 18,020 | $40.03 | $721K | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 100 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 18,020 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 61,849 | $17.46 | $1.08M | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 61,849 | $35.23 | $2.18M | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 61,849 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 22,532 | $17.46 | $393K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 21,232 | $35.63 | $756K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 1,300 | $36.31 | $47K | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 200 | $17.46 | $3K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 200 | $35.01 | $7K | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 22,532 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 200 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 31,338 | $17.46 | $547K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 30,138 | $36.12 | $1.09M | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 1,200 | $36.77 | $44K | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 19,081 | $17.46 | $333K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 19,081 | $36.28 | $692K | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 31,338 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 19,081 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Share Option (right to buy) | 26,198 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Share Option (right to buy) | 26,198 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Immunocore Holdings plc (IMCR) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-28. The full record for IMCR runs to 17 Form 4 filings, the earliest from 2025-05-15. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of IMCR were filed in the last 90 days.
No insider sales of IMCR were filed in the last 90 days. 15 sales are on record for this company.
This page tracks IMCR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add IMCR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
